Michael Gottschalk, MD
Hand Surgery · New York, NYNPI 1659513307
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by United Orthopedics LLC at 43.3% of the total. Reporting peaked in 2022 at $1,348 and has fallen 91.5% since, to $115 in 2025.
Across 28 payments — averaging $98.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Orthopedics LLC$1K
- Stryker$645
- Integra Lifesciences Corporation$348
- Acumed LLC$307
- Smith+Nephew$79
- Restor3d, Inc.$72
- plus $119 from 5 others
Across 12 payments — averaging $142,085 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$1.7M
- Medtronic$35K
What the payments were for
- Food & beverage$1,57057%
- Education$1,20043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Orthopedics LLC | 1 | $1,200 |
| Stryker | 10 | $645 |
| Integra Lifesciences Corporation | 2 | $348 |
| Acumed LLC | 8 | $307 |
| Smith+Nephew | 1 | $79 |
| Restor3d, Inc. | 1 | $72 |
| Catalyst Orthoscience | 1 | $37 |
| Axogen | 1 | $31 |
| Zimmer Biomet | 1 | $25 |
| Osteomed LLC | 1 | $14 |
| Skeletal Dynamics Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,770 in reported general payments places this provider in the 55th percentile of 178 hand surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 74 | $1,292 |
| Methylprednisolone | 104 | $570 |
| Ondansetron Hcl | 163 | $446 |
| Oxycodone Hcl | 137 | $349 |
| Naproxen | 44 | $233 |
| Tramadol Hcl | 105 | $202 |
| Diclofenac Sodium | 12 | $189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $174 |
| Omeprazole | 24 | $102 |
| Diazepam | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in New York
- Nader PaksimaNew York$171K
- Michael HausmanNew York$128K
- Otis BarronNew York$122K
- Dan ZlotolowNew York$91K
- Daniel OseiNew York$51K
- Anthony SapienzaNew York$44K
- Duretti FufaNew York$43K
- Jaehon KimNew York$35K
- Omri AyalonNew York$29K
- Jacques HacquebordNew York$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.